成癮治療市場規模、佔有率、成長分析、按類型、按藥物類型、按治療中心、按分銷管道、按地區 - 行業預測，2024-2031 年

2022年全球成癮治療市場規模將為51億美元，從2023年的54億美元成長到2031年的84.7億美元，在預測期內（2024-2031年）預計複合年成長率為5.80%。

由於成癮率上升、毒品意識提升增強、預防計劃和技術進步等多種因素的綜合作用，成癮治療市場正在經歷顯著擴張。政府的支持和宣傳宣傳活動正在鼓勵更多的人尋求治療，透過各種媒體管道提供的資訊也是如此。隨著受成癮影響的人口增加，新藥物和治療設施（特別是私人康復中心）的出現正在擴大獲得治療的機會。市場成長的一個顯著因素是全球處方藥濫用的快速增加。政府的支持措施，例如宣傳計劃和戒菸治療的有利報銷政策，進一步支持了市場動態。治療方法和藥物方面不斷的技術創新，以及大眾對成癮問題的認知不斷提高，也支持了市場的擴張。 Cipla Inc.、Alkermes 和 Pfizer Inc. 等領先公司正在透過合併和合作夥伴關係對創新解決方案進行策略性投資。該市場涵蓋多種治療類別，包括酒精、菸草和鴉片類藥物成癮，其中由於人們對其健康影響的認知不斷增強，菸草治療預計將成長最快。此外，無線技術在治療設施中變得越來越普遍，復健中心在整體護理方法方面處於市場領先地位。在藥物濫用增加、中階不斷壯大以及政府努力加強醫療保健的推動下，亞太地區預計將出現最高的成長。然而，挑戰仍然存在，特別是治療過程漫長，需要持續監測和多重干涉，這可能會阻礙未來的市場成長。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價值鏈分析
• 市場生態系統
• 案例研究分析
• 監管環境
• 創新矩陣
• 重點投資分析
• 關鍵成功因素
• 競爭程度

成癮治療市場：按類型

• 市場概況
• 酒精成癮治療
• 煙草/尼古丁成癮治療
• 鴉片類藥物成癮治療
• 其他

成癮治療市場：按藥物類型

• 市場概況
• 安非他酮
• Varenicline
• Acamprosate
• Disulfiram
• 納曲酮
• 美沙酮
• Buprenornhine
• 尼古丁替代產品
• 其他

成癮治療市場：依治療中心分類

• 市場概況
• 住宅治療中心
• 門診治療中心
• 住院治療中心

成癮治療市場：依通路分類

• 市場概況
• 零售藥房
• 醫院藥房
• 網路藥房

成癮治療市場：按地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Alkermes plc（Ireland）
• Dr. Reddy's Laboratories Ltd.（India）
• Hikma Pharmaceuticals plc（UK）
• Indivior PLC（UK）
• Mallinckrodt Pharmaceuticals（Ireland）
• Orexo AB（Sweden）
• Pear Therapeutics（US）Inc.（US）
• Pfizer Inc.（US）
• Viatris Inc.（US）
• American Addiction Centers, Inc.（US）
• Quest Diagnostics, Inc.（US）
• Sage Therapeutics, Inc.（US）
• Gilead Sciences, Inc.（US）
• Acadia Pharmaceuticals Inc.（US）
• Medications for Addiction Treatment（MAT）（US）
• Intra-Cellular Therapies, Inc.（US）
• Emergent BioSolutions Inc.（US）
• Hims & Hers Health, Inc.（US）
• Lundbeck A/S（Denmark）
• Cambrex Corporation（US）
• Caron Treatment Centers（US）
• Smart Recovery（US）
• Recovery Brands（US）

Global Addiction Treatment Market size was valued at USD 5.1 billion in 2022 and is poised to grow from USD 5.4 billion in 2023 to USD 8.47 billion by 2031, growing at a CAGR of 5.80% during the forecast period (2024-2031).

The addiction treatment market is witnessing significant expansion driven by a confluence of factors, including rising addiction rates, enhanced drug awareness initiatives, preventive programs, and technological advancements. Government backing and awareness campaigns are prompting more individuals to pursue treatment, bolstered by the availability of information across various media. The emergence of new medications and treatment facilities-especially private recovery centers-has broadened access to care for an increasing population impacted by addiction. A notable contributor to market growth is the global surge in prescription medication misuse. Supportive government measures, including awareness programs and favorable reimbursement policies for smoking cessation therapies, are propelling market dynamics further. Continuous innovation in therapies and medications also promises to fuel expansion, alongside a growing public awareness of addiction issues. Major players like Cipla Inc., Alkermes, and Pfizer Inc. are strategically investing in innovative solutions through mergers and partnerships. The market encapsulates different treatment categories, such as alcohol, tobacco, and opioid addiction, with tobacco treatment poised for the most rapid growth due to heightened awareness of its health impacts. Moreover, wireless addiction treatment technologies are gaining traction within treatment facilities, with rehabilitation centers leading the way due to their holistic care methodologies. The Asia-Pacific region is anticipated to experience the highest growth, driven by increasing substance abuse, an expanding middle class, and governmental efforts to enhance healthcare access. Nonetheless, challenges remain, particularly concerning the lengthy nature of treatment processes that require ongoing monitoring and multiple interventions, which may inhibit future market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the global addiction treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global addiction treatment Market Segmental Analysis

Global Addiction Treatment Market is segmented by Type, Drug Type, Treatment Centers, Distribution Channel, and region. Based on Type, the market is segmented into Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatment, and Others. Based on Drug Type, the market is segmented into Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone, Methadone, Buprenorphine, Nicotine Replacement Products, Others. Based on Treatment Centers, the market is segmented into Residential Treatment Centers, Outpatient Treatment Centers, and Inpatient Treatment Centers. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global addiction treatment Market

The rising prevalence of substance abuse disorders globally is a significant market driver for the addiction treatment market. Increasing awareness about the health and social consequences of addiction is prompting more individuals to seek help, thereby boosting demand for various treatment options, including rehabilitation programs, counseling, and medication-assisted therapies. Additionally, the growing acceptance of mental health issues and the reduction of stigma surrounding addiction are fostering a supportive environment for those in need of treatment. This trend, coupled with advancements in therapeutic techniques and supportive digital platforms, is expected to drive the growth of the global addiction treatment market significantly.

Restraints in the global addiction treatment Market

The global addiction treatment market is likely to encounter significant restraints that may hinder its growth trajectory. The increasing legalization and widespread use of cannabis could lead to a misconception that substance abuse is less severe, potentially reducing demand for traditional addiction treatments. Furthermore, the expiration of patents for key pharmaceutical treatments may result in a rise in generic alternatives, affecting profitability for established companies in the sector. Additionally, the advancement of medical devices specifically designed for opioid addiction treatments may divert interest and resources from conventional therapies, further complicating the market landscape and stalling overall development and investment in addiction treatment solutions.

Market Trends of the global addiction treatment Market

The global addiction treatment market is increasingly shifting towards holistic and personalized care models, reflecting a broader understanding of addiction as a multifaceted issue that encompasses physical, mental, and social dimensions. This evolving market trend sees rehabilitation centers implementing tailored treatment plans that address individual patient needs, providing comprehensive support systems extending beyond traditional therapy and into aftercare. The integration of mental health services, community support, and innovative therapeutic options is enhancing accessibility and effectiveness of treatment. As a result, the sector is experiencing growth driven by a commitment to delivering well-rounded care that promotes lasting recovery and improved quality of life for individuals.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Case study Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Addiction Treatment Market by Type

• Market Overview
• Alcohol Addiction Treatment
• Tobacco/Nicotine Addiction Treatment
• Opioid Addiction Treatment
• Others

Addiction Treatment Market by Drug Type

• Market Overview
• Bupropion
• Varenicline
• Acamprosate
• Disulfiram
• Naltrexone
• Methadone
• Buprenorphine
• Nicotine Replacement Products
• Others

Addiction Treatment Market by Treatment Centers

• Market Overview
• Residential Treatment Centers
• Outpatient Treatment Centers
• Inpatient Treatment Centers

Addiction Treatment Market by Distribution Channel

• Market Overview
• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

Addiction Treatment Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Alkermes plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indivior PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orexo AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pear Therapeutics (US) Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Addiction Centers, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sage Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acadia Pharmaceuticals Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medications for Addiction Treatment (MAT) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intra-Cellular Therapies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hims & Hers Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lundbeck A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambrex Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caron Treatment Centers (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smart Recovery (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recovery Brands (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments